ALDH1A3 anticorps (AA 1-100, AA 413-512)

N° du produit ABIN2715885

Détail du produit anti-ALDH1A3 anticorps

Antigène: ALDH1A3 (Aldehyde Dehydrogenase 1 Family, Member A3 (ALDH1A3))

Épitope: AA 1-100, AA 413-512

Reactivité: Humain, Chien, Singe

Hôte: Souris

Clonalité: Monoclonal

Conjugué: Cet anticorp ALDH1A3 est non-conjugé

Application: Western Blotting (WB), Immunohistochemistry (IHC), Flow Cytometry (FACS)

Purification: Purified from mouse ascites fluids by affinity chromatography

Immunogène: Human recombinant protein fragment corresponding to amino acids 1-100 and AA 413-512 of human ALDH1A3 (NP_000648) produced in E.coli.

Clone: OTI4B6

Isotype: IgG1

Information d'application

Indications d'application: WB 1:200, IHC 1:150, FLOW 1:100,

Restrictions: For Research Use only

Stockage

Format: Liquid

Concentration: 1 mg/mL

Références pour anticorps anti-ALDH1A3 (ABIN2715885)

Wang, Song, Guo, Wang, Yin: "Establishment of MAGEC2-knockout cells and functional investigation of MAGEC2 in tumor cells." dans: Cancer science, Vol. 107, Issue 12, pp. 1888-1897, (2017) (PubMed).

Qiu, Pu, Guo, Wei, Zhang, Zhang, Zhong, Zheng, Chen, Bu, Ye: "ALDH(+)/CD44(+) cells in breast cancer are associated with worse prognosis and poor clinical outcome." dans: Experimental and molecular pathology, Vol. 100, Issue 1, pp. 145-50, (2016) (PubMed).

Détails sur ALDH1A3

Antigène: ALDH1A3 (Aldehyde Dehydrogenase 1 Family, Member A3 (ALDH1A3))

Autre désignation: ALDH1A3 (ALDH1A3 Produits)

Synonymes: anticorps RALDH3, anticorps ALDH1A3, anticorps ALDH1A6, anticorps ALDH6, anticorps MCOP8, anticorps Aldh6, anticorps V1, anticorps aldehyde dehydrogenase 1 family member A3, anticorps aldehyde dehydrogenase 1 family member A3 L homeolog, anticorps aldehyde dehydrogenase 1 family, member A3, anticorps aldehyde dehydrogenase family 1, subfamily A3, anticorps ALDH1A3, anticorps aldh1a3.L, anticorps aldh1a3, anticorps Aldh1a3

Poids moléculaire: 55.9 kDa

NCBI Accession: NM_000693

HGNC: 220

Pathways: Retinoic Acid Receptor Signaling Pathway